Citigroup’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.62M | Buy |
33,714
+32,021
| +1,891% | +$1.42M | ﹤0.01% | 2805 |
|
|
2025
Q4 | $69.8K | Sell |
1,693
-8,071
| -83% | -$324K | ﹤0.01% | 4462 |
|
|
2025
Q3 | $379K | Sell |
9,764
-43,438
| -82% | -$1.41M | ﹤0.01% | 3709 |
|
|
2025
Q2 | $1.47M | Buy |
53,202
+20,095
| +61% | +$512K | ﹤0.01% | 2913 |
|
|
2025
Q1 | $735K | Sell |
33,107
-28,375
| -46% | -$584K | ﹤0.01% | 3455 |
|
|
2024
Q4 | $1.22M | Buy |
61,482
+29,786
| +94% | +$680K | ﹤0.01% | 3211 |
|
|
2024
Q3 | $792K | Buy |
31,696
+23,802
| +302% | +$580K | ﹤0.01% | 3444 |
|
|
2024
Q2 | $147K | Sell |
7,894
-183,126
| -96% | -$3.43M | ﹤0.01% | 4034 |
|
|
2024
Q1 | $3.77M | Buy |
191,020
+144,662
| +312% | +$2.83M | ﹤0.01% | 1926 |
|
|
2023
Q4 | $813K | Sell |
46,358
-17,793
| -28% | -$292K | ﹤0.01% | 3015 |
|
|
2023
Q3 | $1.11M | Buy |
64,151
+15,825
| +33% | +$267K | ﹤0.01% | 2414 |
|
|
2023
Q2 | $680K | Sell |
48,326
-85,035
| -64% | -$1.14M | ﹤0.01% | 3140 |
|
|
2023
Q1 | $1.43M | Buy |
133,361
+90,253
| +209% | +$1.19M | ﹤0.01% | 2260 |
|
|
2022
Q4 | $646K | Buy |
43,108
+41,230
| +2,195% | +$600K | ﹤0.01% | 2987 |
|
|
2022
Q3 | $24K | Sell |
1,878
-2,763
| -60% | -$31.5K | ﹤0.01% | 4671 |
|
|
2022
Q2 | $45K | Buy |
4,641
+1,780
| +62% | +$16.6K | ﹤0.01% | 4581 |
|
|
2022
Q1 | $29K | Sell |
2,861
-70,965
| -96% | -$752K | ﹤0.01% | 4966 |
|
|
2021
Q4 | $869K | Buy |
73,826
+14,656
| +25% | +$180K | ﹤0.01% | 3389 |
|
|
2021
Q3 | $674K | Sell |
59,170
-99,785
| -63% | -$1.3M | ﹤0.01% | 3407 |
|
|
2021
Q2 | $2.21M | Buy |
158,955
+21,894
| +16% | +$333K | ﹤0.01% | 2592 |
|
|
2021
Q1 | $2.54M | Buy |
137,061
+130,556
| +2,007% | +$2.67M | ﹤0.01% | 2331 |
|
|
2020
Q4 | $115K | Buy |
6,505
+4,944
| +317% | +$86.8K | ﹤0.01% | 5428 |
|
|
2020
Q3 | $24K | Sell |
1,561
-4,130
| -73% | -$77.5K | ﹤0.01% | 6052 |
|
|
2020
Q2 | $145K | Buy |
5,691
+1,745
| +44% | +$36.5K | ﹤0.01% | 5263 |
|
|
2020
Q1 | $61K | Buy |
3,946
+1,149
| +41% | +$18K | ﹤0.01% | 5791 |
|
|
2019
Q4 | $31K | Buy |
2,797
+1,623
| +138% | +$14.1K | ﹤0.01% | 6687 |
|
|
2019
Q3 | $10K | Sell |
1,174
-3,152
| -73% | -$34.8K | ﹤0.01% | 7068 |
|
|
2019
Q2 | $58K | Buy |
4,326
+900
| +26% | +$14K | ﹤0.01% | 6334 |
|
|
2019
Q1 | $62K | Buy |
3,426
+2,033
| +146% | +$39.3K | ﹤0.01% | 6160 |
|
|
2018
Q4 | $40K | Sell |
1,393
-492
| -26% | -$10.3K | ﹤0.01% | 6418 |
|
|
2018
Q3 | $48K | Buy |
+1,885
| New | +$36.7K | ﹤0.01% | 6555 |
|
Other funds holding KNSA
RCMNY
BBA
TCM
VPM
VCM
